Literature DB >> 17130422

Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging.

H V Danesh-Meyer1, H Birch, J Y-F Ku, S Carroll, G Gamble.   

Abstract

In this case-control study, we compared the optic nerves (ONs) by clinical examination and scanning laser ophthalmoscopy (SLO) of 40 patients with Alzheimer disease (AD) and 50 controls. There was a reduction in the number of ON fibers in patients with AD, with a threefold greater odds ratio for a larger optic cup-to-disc ratio in patients with AD.

Entities:  

Mesh：

Year:  2006        PMID： 17130422     DOI： 10.1212/01.wnl.0000244490.07925.8b

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  53 in total

1.  Peripheral Retinal Imaging Biomarkers for Alzheimer's Disease: A Pilot Study.

Authors:  Lajos Csincsik; Thomas J MacGillivray; Erin Flynn; Enrico Pellegrini; Giorgos Papanastasiou; Neda Barzegar-Befroei; Adrienne Csutak; Alan C Bird; Craig W Ritchie; Tunde Peto; Imre Lengyel
Journal:  Ophthalmic Res       Date:  2018-04-05       Impact factor: 2.892

2.  Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease.

Authors:  Sylvia E Perez; Stephen Lumayag; Beatrix Kovacs; Elliott J Mufson; Shunbin Xu
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-12       Impact factor: 4.799

Review 3.  Ophthalmic manifestations of inherited neurodegenerative disorders.

Authors:  Hannah M Kersten; Richard H Roxburgh; Helen V Danesh-Meyer
Journal:  Nat Rev Neurol       Date:  2014-05-20       Impact factor: 42.937

4.  A Meta-analysis of Retinal Cytoarchitectural Abnormalities in Schizophrenia and Bipolar Disorder.

Authors:  Paulo Lizano; Deepthi Bannai; Olivia Lutz; Leo A Kim; John Miller; Matcheri Keshavan
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

5.  The c-jun N-terminal kinase plays a key role in ocular degenerative changes in a mouse model of Alzheimer disease suggesting a correlation between ocular and brain pathologies.

Authors:  Lucia Buccarello; Alessandra Sclip; Matteo Sacchi; Anna Maria Castaldo; Ilaria Bertani; Andrea ReCecconi; Silvia Maestroni; Gianpaolo Zerbini; Paolo Nucci; Tiziana Borsello
Journal:  Oncotarget       Date:  2017-08-03

Review 6.  Low-level light therapy of the eye and brain.

Authors:  Julio C Rojas; F Gonzalez-Lima
Journal:  Eye Brain       Date:  2011-10-14

7.  Retinal Biomarkers of Alzheimer Disease.

Authors:  Cecilia S Lee; Rajendra S Apte
Journal:  Am J Ophthalmol       Date:  2020-05-06       Impact factor: 5.258

8.  Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease.

Authors:  Allison Ning; Jing Cui; Eleanor To; Karen Hsiao Ashe; Joanne Matsubara
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-19       Impact factor: 4.799

9.  Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice.

Authors:  Bingqian Liu; Suhail Rasool; Zhikuan Yang; Charles G Glabe; Steven S Schreiber; Jian Ge; Zhiqun Tan
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

10.  Methylene blue provides behavioral and metabolic neuroprotection against optic neuropathy.

Authors:  Julio C Rojas; Joseph M John; Jung Lee; F Gonzalez-Lima
Journal:  Neurotox Res       Date:  2009-02-24       Impact factor: 3.911
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.